Biogen solicitará a los reguladores de medicamentos de EEUU que aprueben su terapia experimental contra el Alzheimer

Biogen Inc. will ask U.S. drug regulators to approve the company’s experimental Alzheimer’s therapy, reviving the nearly abandoned treatment after a new analysis of data from two failed clinical trials showed promising results.

Fuente: Youtube